Emerging technologies have driven cell and gene therapies to the forefront of healthcare, addressinga growing number of disease conditions including rare diseases with unmet medical needs.CGT trials are long, incredibly complex, and riddled with unknowns, that is why advancingdevelopment in these areas requires special expertise and the ability to tailor services across allstages of drug development.PPD has deep experience partnering with clients to advance development of their cell and genetherapy trials across numerous indications and all development phases.